Immunotherapy clinical trial assesses opportunity to prevent lung cancer development, recurrence
An immunotherapy used to treat advanced lung cancer is tested in a clinical trial to prevent the disease by eradicating precancerous growths.
Related Articles
9 things to know about sunglasses, eye protection and cancer
What should you look for when shopping for sunglasses? How do you know if they offer enough UV protection? And, are some lens colors considered…
Antibody treatment is safe for elderly patients with relapsed/refractory multiple myeloma
Antibody treatment is safe for elderly patients with relapsed/refractory multiple myeloma
Biomarker-guided combination therapy targets subtype of advanced prostate cancer
Biomarker-guided combination therapy targets subtype of advanced prostate cancer
Sickle cell disease changes DNA structure of cells to suppress immunity
Sickle cell disease changes DNA structure of cells to suppress immunity
How much caffeine is too much?
How much caffeine is it OK to drink a day? And what happens if you drink too much? Clinical dietitian Kaylie Brown answers these questions…
Interstitial cystitis symptoms and bladder cancer: Is there a connection?
What is interstitial cystitis? How is it treated? And, does the condition also known as bladder pain syndrome ever increase your chances of developing bladder…
Mapping changes in lung precancer reveals TIM-3 as potential intervention target
Mapping changes in lung precancer reveals TIM-3 as potential intervention target
Demystifying the well-woman: What to expect during this annual exam
What happens during a typical well-woman exam? Gynecologist Elizabeth Keeler, M.D. explains what to expect during these important annual doctor visits — and why you…
Self-advocacy may lead to less pain in older breast cancer survivors
Self-advocacy leads to less pain in older breast cancer survivors
All roads led to MD Anderson for nursing institute head
Sadie Hutson, Ph.D., has spent most of her personal and professional life dealing with cancer in one way or another. Now, she’s putting her personal…